abstract |
The present invention relates to peroral pharmaceutical compositions, which release levosimendan in a controlled mode with a reduced occurrence of undesirable effects. Levosimendan, or (-) - [[4- (1,4,5,6-tetrahydro-4-methyl-6-oxo-3- pyridazinyl) feni] -hydrazono? Propanedinitrile, is useful in the treatment of cardiac arrest congestive |